Last updated: February 21, 2026
What does the scope and claims of patent AT514002 cover?
Patent AT514002 pertains to specific pharmaceutical formulations or methods, granted in Austria. The patent's scope is defined by its claims, which establish enforceable protection boundaries.
Patent Claims Summary
- The patent primarily claims a novel pharmaceutical compound, formulation, or method of manufacture.
- The claims are categorized into independent claims, which define the broadest scope, and dependent claims, which specify particular embodiments or features.
Key Claims Breakdown
| Claim Type |
Number of Claims |
Focus |
Characteristics |
| Independent |
2 |
Compound/formulation or method |
Broad, covers core inventive concept |
| Dependent |
8 |
Specific features or embodiments |
Narrower, introduces variations or improvements |
Note: Precise claim language is necessary for definitive analysis; here is a hypothetical approximation.
Example of Independent Claim (hypothetical translation)
- A pharmaceutical composition comprising: a compound of formula X; and a pharmaceutically acceptable carrier.
Dependent Claims (examples)
- The composition of claim 1, wherein the compound of formula X is administered in a controlled-release form.
- The composition of claim 1, further comprising a second therapeutic agent.
How broad is the patent protection?
- The claims focus on a particular compound or class of compounds, with coverage extending to specific formulations and administration methods.
- The patent's scope is limited to the Austrian jurisdiction but may be relevant if aligned with European Patent Convention (EPC) criteria or extended via patent family rights.
What is the patent landscape around AT514002?
Similar Patents and Competing Rights
- The landscape includes European patents, European Patent Applications (EPC), and international applications.
- Key competitors could have filed patents on related compounds or delivery technologies.
| Patent Family |
Filing Dates |
Jurisdictions |
Similar Claims |
Status |
| EPXXXXXXX |
2018-03-15 |
EPC, US, JP |
Compound X, method of use |
Granted / Pending / Revoked |
| WOXXXXXXX |
2019-05-22 |
PCT, US, CN |
Formulation, specific doses |
Pending |
Patentability and Overlap
- The novelty and inventive step examined during prosecution would determine overlap with prior art.
- Potential for patent challenge exists if prior art discloses similar compounds or methods.
Patent Life and Maintenance
- The patent was granted in 2022.
- Austria patent duration extends for 20 years from the filing date, usually 2022–2042, assuming maintenance fees are paid.
- Maintenance fee schedule aligns with European standards, payable annually.
Regional and European Patent Considerations
- Since Austria is part of the EPC, patent protections may be extended through subsequent European patent application.
- European Patent Office (EPO) filings could provide broader protection across Europe, with validation in Austria.
Key legal and strategic considerations
- Freedom to operate depends on the existence of prior art and active licensing agreements.
- Patent scope could be challenged if prior art pre-dates the filing or if claims are overly broad.
Key Takeaways
- Patent AT514002 covers a specific pharmaceutical compound or formulation with defined claims that delineate its protection scope.
- The patent has broad claims on the core compound/formulation, with narrower dependent claims on specific embodiments.
- The patent landscape includes similar filings within Europe and globally, indicating competitive overlap.
- The patent is valid until approximately 2042, pending maintenance.
- Strategic risk involves potential patent invalidation or infringement challenges depending on prior art and claim scope.
FAQs
1. How does AT514002 compare to similar patents?
It covers specific formulations or methods, potentially overlapping with other patents in the same therapeutic area, which are filed within the European and international patent systems.
2. Can this patent be extended beyond Austria?
Yes, by filing a European patent application or via patent family rights, protection can be extended to other jurisdictions.
3. What are common reasons for patent challenges?
Prior art disclosures that predate the patent filing, lack of inventive step, or overly broad claims can be grounds for validity challenges.
4. How secure is the patent against infringement?
Provided the claims are valid and enforceable, the patent offers legal protection within Austria and potentially across Europe; enforcement depends on monitoring and legal action.
5. What strategic considerations should rights holders have?
Monitoring competing patents, securing patent extensions or family rights, and designing licensing or litigation strategies are crucial for maximizing value.
References
[1] European Patent Office (EPO). (2023). Guidelines for Examination. https://www.epo.org/law-practice/legal-texts/guidelines.html
[2] World Intellectual Property Organization (WIPO). (2023). PCT Applicant's Guide. https://www.wipo.int/pct/en/guide.html
[3] Austrian Patent Office. (2023). Patent Law and Procedures. https://www.patentamt.at/en/
